iToBoS

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 965221

Skin cancer is the most common human malignancy and its incidence has been increasing in the last decade. Within the general category of skin cancers, melanoma constitutes the main cause of death. Fortunately, melanoma may be cured if treated at an early stage.

However, early-stage melanoma detection is not easy even for expert dermatologists, and due to the labor, time and cost intensive state-of-the-art process of manually screening each patient using hand held dermoscopes, only a small fraction of the skin area can be covered with reasonable expenditure of resources. The risk of missing a melanoma therefore remains significant.

The iToBoS research project, funded by European Union's Horizon 2020 reasearch programme, will develop a novel diagnostic tool in for of an AI-driven total body scanner combining different sources of patient data, to significantly speed up the melanoma screening process, and minimize the associated healthcare costs, while providing transparent feedback to expert clinitians about the AI's diagnoses. The combination of all this personalized information will result in an accurate, detailed and structured assessment of the pigmented skin lesions of the patient.